138 related articles for article (PubMed ID: 34621116)
1. Studies on the cholinesterases inhibiting compounds from the Cassiopea andromeda venom.
Darabi AH; Nabipour I; Mohebbi G; Vazirizadeh A; Vatanpour H; Maryamabadi A
Bioinformation; 2020; 16(9):702-709. PubMed ID: 34621116
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom.
Shamsian S; Nabipour I; Mohebbi G; Baghban N; Zare M; Zandi K; Vazirizadeh A; Maryamabadi A; Delattre C
Microb Pathog; 2024 Jan; 186():106486. PubMed ID: 38056601
[TBL] [Abstract][Full Text] [Related]
3. The Effect of the Persian Gulf Jellyfish (Cassiopea andromeda) Venom on the Expression of P15, P21, P53, DNMT1, and Bcl-2 in Acute Lymphoblastic Leukemia Jurkat Cells.
Dehghani R; Amrooni A; Hosseinpour-Soleimani F; Mohebbi G; Obeidi N
Int J Hematol Oncol Stem Cell Res; 2023 Jul; 17(3):177-185. PubMed ID: 37817966
[No Abstract] [Full Text] [Related]
4. Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study.
Cortes N; Sierra K; Alzate F; Osorio EH; Osorio E
Phytochem Anal; 2018 Mar; 29(2):217-227. PubMed ID: 29044771
[TBL] [Abstract][Full Text] [Related]
5. Hematological parameters on the effect of the jellyfish venom
Nabipour I; Mohebbi G; Vatanpour H; Vazirizadeh A
Data Brief; 2017 Apr; 11():517-521. PubMed ID: 28331896
[TBL] [Abstract][Full Text] [Related]
6. Chemical Compositions and Experimental and Computational Modeling of the Anticancer Effects of Cnidocyte Venoms of Jellyfish
Zare A; Afshar A; Khoradmehr A; Baghban N; Mohebbi G; Barmak A; Daneshi A; Bargahi A; Nabipour I; Almasi-Turk S; Arandian A; Zibaii MI; Latifi H; Tamadon A
Mar Drugs; 2023 Mar; 21(3):. PubMed ID: 36976217
[TBL] [Abstract][Full Text] [Related]
7. Persian Gulf Jellyfish (Cassiopea andromeda) Venom Fractions Induce Selective Injury and Cytochrome C Release in Mitochondria Obtained from Breast Adenocarcinoma Patients.
Mirshamsi MR; Omranipour R; Vazirizadeh A; Fakhri A; Zangeneh F; Mohebbi GH; Seyedian R; Pourahmad J
Asian Pac J Cancer Prev; 2017 Jan; 18(1):277-286. PubMed ID: 28240847
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
11. A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives.
Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
Bioorg Med Chem Lett; 2018 Aug; 28(14):2481-2484. PubMed ID: 29887354
[TBL] [Abstract][Full Text] [Related]
12. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species.
Ortiz JE; Garro A; Pigni NB; Agüero MB; Roitman G; Slanis A; Enriz RD; Feresin GE; Bastida J; Tapia A
Phytomedicine; 2018 Jan; 39():66-74. PubMed ID: 29433685
[TBL] [Abstract][Full Text] [Related]
14. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
15. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
Lee S; Youn K; Lim G; Lee J; Jun M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
[TBL] [Abstract][Full Text] [Related]
16. A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies.
Özçelik AB; Özdemir Z; Sari S; Utku S; Uysal M
Pharmacol Rep; 2019 Dec; 71(6):1253-1263. PubMed ID: 31675671
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
18. Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
Munir R; Zia-Ur-Rehman M; Murtaza S; Zaib S; Javid N; Awan SJ; Iftikhar K; Athar MM; Khan I
Molecules; 2021 Jan; 26(3):. PubMed ID: 33513837
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
Kia Y; Osman H; Suresh Kumar R; Basiri A; Murugaiyah V
Bioorg Med Chem Lett; 2014 Apr; 24(7):1815-9. PubMed ID: 24594354
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the toxinological characteristics of two Cassiopea and Aurelia species.
Radwan FF; Burnett JW; Bloom DA; Coliano T; Eldefrawi ME; Erderly H; Aurelian L; Torres M; Heimer-de la Cotera EP
Toxicon; 2001; 39(2-3):245-57. PubMed ID: 10978742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
